Literature DB >> 6389849

Effects of mitochondrial protein synthesis inhibitors on the incorporation of isoleucine into Plasmodium falciparum in vitro.

J J Blum, A Yayon, S Friedman, H Ginsburg.   

Abstract

Plasmodium falciparum was grown in human erythrocytes in vitro and the effect of chloramphenicol, erythromycin, and tetracycline on growth and maturation of the parasites and on their ability to incorporate [3H]isoleucine into protein was observed. Exposure of rings to high concentrations of chloramphenicol had little effect on subsequent maturation of the rings whereas brief (4 h) exposure of trophozoites caused a dose-dependent inhibition of subsequent ring formation. Incorporation of [3H]isoleucine into protein was not affected during at least 6 h of exposure to high concentration of the three drugs examined, but appreciable inhibition was observed after 21 h, with chloramphenicol being the least effective inhibitor. These results suggest that there is a stage-specific effect of inhibition of mitochondrial protein synthesis on subsequent development and that the mitochondria are essential for growth and development even though they lack a functional Krebs cycle.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389849     DOI: 10.1111/j.1550-7408.1984.tb02997.x

Source DB:  PubMed          Journal:  J Protozool        ISSN: 0022-3921


  11 in total

1.  Inhibition of malaria parasite invasion of human erythrocytes by a lymphocyte membrane polypeptide.

Authors:  R Benzaquen-Geffin; Y Milner; H Ginsburg
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

2.  Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

Authors:  C J Beckers; D S Roos; R G Donald; B J Luft; J C Schwab; Y Cao; K A Joiner
Journal:  J Clin Invest       Date:  1995-01       Impact factor: 14.808

3.  Complex transcription from the extrachromosomal DNA encoding mitochondrial functions of Plasmodium yoelii.

Authors:  K Suplick; J Morrisey; A B Vaidya
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

4.  Plasmodium falciparum proteome changes in response to doxycycline treatment.

Authors:  Sébastien Briolant; Lionel Almeras; Maya Belghazi; Elodie Boucomont-Chapeaublanc; Nathalie Wurtz; Albin Fontaine; Samuel Granjeaud; Thierry Fusaï; Christophe Rogier; Bruno Pradines
Journal:  Malar J       Date:  2010-05-25       Impact factor: 2.979

5.  Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline.

Authors:  Sébastien Briolant; Meili Baragatti; Philippe Parola; Fabrice Simon; Adama Tall; Cheikh Sokhna; Philippe Hovette; Modeste Mabika Mamfoumbi; Jean-Louis Koeck; Jean Delmont; André Spiegel; Jacky Castello; Jean Pierre Gardair; Jean Francois Trape; Maryvonne Kombila; Philippe Minodier; Thierry Fusai; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2008-12-01       Impact factor: 5.191

6.  Effects of red blood cell potassium and hypertonicity on the growth of Plasmodium falciparum in culture.

Authors:  H Ginsburg; S Handeli; S Friedman; R Gorodetsky; M Krugliak
Journal:  Z Parasitenkd       Date:  1986

7.  Sequence identification of cytochrome b in Plasmodium gallinaceum.

Authors:  S M Aldritt; J T Joseph; D F Wirth
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

8.  Effects of cinnamic acid derivatives on in vitro growth of Plasmodium falciparum and on the permeability of the membrane of malaria-infected erythrocytes.

Authors:  J Kanaani; H Ginsburg
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

9.  Quinine specifically inhibits the proteolipid subunit of the F0F1 H+ -ATPase of Streptococcus pneumoniae.

Authors:  R Muñoz; E García; A G De la Campa
Journal:  J Bacteriol       Date:  1996-04       Impact factor: 3.490

Review 10.  Tetracyclines in malaria.

Authors:  Tiphaine Gaillard; Marylin Madamet; Bruno Pradines
Journal:  Malar J       Date:  2015-11-10       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.